Dynamics of Anti-ABO(H) Antibody Expression in SARS-CoV-2-Infected Patients.

Publication date: Sep 28, 2026

The association between ABO(H) blood groups and COVID-19 susceptibility and severity has been studied throughout the pandemic. However, the comprehensively tracked dynamic changes of antibodies to ABO(H) over the course of COVID-19 infection remain poorly characterized. Here, we present a longitudinal cohort study that tracked changes in anti-ABO(H) antibody levels and isotypes in serum of 65 COVID-19 patients. Sera were collected at (1) time of hospital admission, (2) 2-3 weeks after symptom onset, and (3) just before hospital discharge or death. Anti-ABO(H) glycan-specific IgG, IgM, and IgA isotypes were profiled using high-throughput Luminex assays, employing beads derivatized with glycans representing the major ABO(H) antigens. While each patient demonstrated unique repertoires of anti-ABO(H) antibodies, unexpected changes in isotypes were observed, indicating varied impact on naturally occurring antibody levels following SARS-CoV-2 infection. Interestingly, blood group O patients showed a higher likelihood of possessing anti-ABO(H) IgA than other blood types. Additionally, we identified autoantibodies against non-blood-group self-glycans in a small proportion of the cohort. Data suggest that exposure to virus represents an underappreciated factor influencing anti-ABO(H) antibody profiles. These results provide a deeper understanding of the potential interplay between anti-ABO(H) antibodies and progression of SARS-CoV-2 infection.

Open Access PDF

Concepts Keywords
Antibodies Aboh
Death Anti
Hospital Antibodies
Underappreciated Antibody
Weeks Blood
Cohort
Cov
Covid
Hospital
Iga
Infection
Isotypes
Patients
Sars
Tracked

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH death
pathway REACTOME SARS-CoV-2 Infection

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *